Minocycline protects SH-SY5Y cells from 6-hydroxydopamine by inhibiting both caspase-dependent and -independent programmed cell death

Neuroprotective Effects of Tetracyclines: Molecular Targets, Animal Models and Human Disease

(2012) D. Orsucci et al.   CNS & Neurological Disorders-Drug Targets

Identification of new modulators and protein alterations in non-apoptotic programmed cell death

(2010) Sabina Sperandio et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Impairment of mitochondrial function by minocycline

(2009) Kathleen Kupsch et al.   FEBS Journal

The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease

(2008) T. Pan et al.   BRAIN

Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures

(2008) Tiina M. Kääriäinen et al.   BRAIN RESEARCH

A Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson Disease

(2008)   CLINICAL NEUROPHARMACOLOGY

Time-dependent protective and harmful effects of quercetin on 6-OHDA-induced toxicity in neuronal SH-SY5Y cells

(2008) Bernardino Ossola et al.   TOXICOLOGY

1-Nitropyrene (1-NP) induces apoptosis and apparently a non-apoptotic programmed cell death (paraptosis) in Hepa1c1c7 cells

(2008) Nana Asare et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY